ALFUZOSIN Mepha retard cpr ret 10 mg 30 pce
7680681380023
CH-68138
G04CA01
05.99.0.
1 / 3
google
Details
- Product number
- 6813801
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- alfuzosini hydrochloridum 10 mg, hypromellosum, lactosum monohydricum 8 mg, povidonum K 25, magnesii stearas, pro compresso.
Articles (1)
Alfuzosin-Mepha retard, Retardtabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
8.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 30.70
Specialties list
Yes
Generic
Yes
SL addition date:
01/02/2021
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 68138
- Drug name
- Alfuzosin-Mepha retard, Retardtabletten
- Galenic form
- RETT
- ATC Code
- G04CA01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 15/10/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 05.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ALFUZOSIN Mepha retard cpr ret 10 mg 30 pce
- Description (DE)
- ALFUZOSIN Mepha retard Ret Tabl 10 mg 30 Stk
- Market launch
- 15/10/2020
- Narcotic (BTM)
- No